Array Biopharma Inc (ARRY)

HEALTH CARE: PHARMACEUTICALS

3200 WALNUT STREET BOULDER, CO 80301

Operates as a biopharmaceutical company that focuses on the discovery, development and commercialization of orally active drugs to address significant unmet medical needs. Its proprietary drug development pipeline is primarily focused on the treatment of cancer and inflammatory disease.

View SEC Filings from ARRY instead.
Filers who had this stock in their top 10: 7
13F Filers holding this stock: 185
Aggregate 13F shares on 12/31/2017: 196.99 Million
Aggregate 13F shares on 09/30/2017: 193.343 Million
Percent change: 1.89%
Funds creating new positions: 34
Funds Adding to an existing position: 73
Funds closing out their position: 29
Funds reducing their position: 56
View recent insider trading info

Funds Holding ARRY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
to
to
to

Include:

Exclude:

Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

150.5 Thousand total shares from 5 transactions

Exercise Derivative Conversion (M)

157 Thousand total shares from 9 transactions

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Acquired or Disposed Shares Owned Following Transaction Direct/Indirect Ownership

VAN LUNSEN GIL J

2018-02-21 S 21,500 d 19,297 direct

VAN LUNSEN GIL J

2018-02-21 M 8,000 d 7,000 direct

VAN LUNSEN GIL J

2018-02-21 M 13,500 d 0 direct

VAN LUNSEN GIL J

2018-02-21 M 13,500 a 32,797 direct

VAN LUNSEN GIL J

2018-02-21 M 8,000 a 40,797 direct

BAUM CHARLES M

2018-02-09 M 25,000 a 35,000 direct

BAUM CHARLES M

2018-02-09 M 25,000 a 60,000 direct

LEFKOFF KYLE

2018-02-09 M 25,000 a 42,720 direct

BAUM CHARLES M

2018-02-09 S 50,000 d 10,000 direct

LEFKOFF KYLE

2018-02-09 M 25,000 a 67,720 direct

BAUM CHARLES M

2018-02-09 M 25,000 d 0 direct

LEFKOFF KYLE

2018-02-09 S 50,000 d 17,720 direct

BAUM CHARLES M

2018-02-09 M 25,000 d 0 direct

LEFKOFF KYLE

2018-02-09 M 25,000 d 0 direct

LEFKOFF KYLE

2018-02-09 M 25,000 d 0 direct

VAN LUNSEN GIL J

2018-01-17 M 15,000 d 0 direct

VAN LUNSEN GIL J

2018-01-17 M 15,000 a 34,297 direct

VAN LUNSEN GIL J

2018-01-17 M 6,500 a 40,797 direct

VAN LUNSEN GIL J

2018-01-17 S 21,500 d 19,297 direct

VAN LUNSEN GIL J

2018-01-17 M 6,500 d 13,500 direct

HADDOCK JASON CFO

2018-01-16 M 14,025 a 36,368 direct

HADDOCK JASON CFO

2018-01-16 S 7,500 d 28,868 direct

HADDOCK JASON CFO

2018-01-16 M 14,025 d 540,975 direct
Click here to report any possible errors with this stock listing.

Elevate your investments